Clinical Trial Update: Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 trial investigating parathyroid hormone for treatment of adynamic bone disorder in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adynamic Bone Disease
• Cardiac Disease
• Chronic Kidney Disease
• Chronic Kidney Disease-mineral and Bone Disorder

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: Ditte Hansen | Conditions: Adynamic Bone Disease, Chronic Kidney Diseases | Phase 4 | Status: RECRUITING